Literature DB >> 18817515

Enhanced composite electrospun nanofiber scaffolds for use in drug delivery.

Michael Hadjiargyrou1, Jonathan B Chiu.   

Abstract

The utility of nanofibrous electrospun composite scaffolds has greatly expanded over the last decade, so that they now serve as viable drug delivery vehicles for a host of different biomedical applications. The material properties of electrospun scaffolds are extremely advantageous for drug delivery, in which site-specificity and lower overall medicinal dosages lead to a potential industry-altering mechanism of delivering therapeutics. Different drugs used to predominantly treat infections and cancers can easily be incorporated and released at therapeutic dosages. Further, the inherent high porosity of these electrospun scaffolds allows for a more precisely controlled degradation which is tunable by polymer composition and fiber morphology, leading to sustained drug release. This review examines the current research and breakthrough discoveries that have elevated electrospun scaffolds to a cutting-edge technology that will dramatically alter the landscape of drug delivery.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18817515     DOI: 10.1517/17425247.5.10.1093

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  9 in total

1.  Electrospun blends of gelatin and gelatin-dendrimer conjugates as a wound-dressing and drug-delivery platform.

Authors:  Alpana A Dongargaonkar; Gary L Bowlin; Hu Yang
Journal:  Biomacromolecules       Date:  2013-10-30       Impact factor: 6.988

2.  Use of periplasmic target protein capture for phage display engineering of tight-binding protein-protein interactions.

Authors:  Bartlomiej G Fryszczyn; Nicholas G Brown; Wanzhi Huang; Miriam A Balderas; Timothy Palzkill
Journal:  Protein Eng Des Sel       Date:  2011-09-06       Impact factor: 1.650

3.  An anisotropic nanofiber/microsphere composite with controlled release of biomolecules for fibrous tissue engineering.

Authors:  Lara C Ionescu; Gregory C Lee; Brian J Sennett; Jason A Burdick; Robert L Mauck
Journal:  Biomaterials       Date:  2010-02-10       Impact factor: 12.479

4.  Astrocytes increase ATP exocytosis mediated calcium signaling in response to microgroove structures.

Authors:  Ajay V Singh; Michael Raymond; Fabiano Pace; Anthony Certo; Jonathan M Zuidema; Christopher A McKay; Ryan J Gilbert; X Lucas Lu; Leo Q Wan
Journal:  Sci Rep       Date:  2015-01-19       Impact factor: 4.379

5.  Targeted concurrent and sequential delivery of chemotherapeutic and antiangiogenic agents to the brain by using drug-loaded nanofibrous membranes.

Authors:  Yuan-Yun Tseng; Tao-Chieh Yang; Yi-Chuan Wang; Wei-Hwa Lee; Tzu-Min Chang; Yi-Chuan Kau; Shih-Jung Liu
Journal:  Int J Nanomedicine       Date:  2017-02-14

6.  Electrospun Polyhydroxybutyrate/Poly(ε-caprolactone)/Sol-Gel-Derived Silica Hybrid Scaffolds with Drug Releasing Function for Bone Tissue Engineering Applications.

Authors:  Yaping Ding; Wei Li; Alexandra Correia; Yuyun Yang; Kai Zheng; Dongfei Liu; Dirk W Schubert; Aldo R Boccaccini; Hélder A Santos; Judith A Roether
Journal:  ACS Appl Mater Interfaces       Date:  2018-04-17       Impact factor: 9.229

Review 7.  Relating Advanced Electrospun Fiber Architectures to the Temporal Release of Active Agents to Meet the Needs of Next-Generation Intravaginal Delivery Applications.

Authors:  Kevin M Tyo; Farnaz Minooei; Keegan C Curry; Sarah M NeCamp; Danielle L Graves; Joel R Fried; Jill M Steinbach-Rankins
Journal:  Pharmaceutics       Date:  2019-04-03       Impact factor: 6.321

Review 8.  Nanofiber-based systems intended for diabetes.

Authors:  Hassan Maleki; Kamyar Khoshnevisan; Sayed Mahmoud Sajjadi-Jazi; Hadi Baharifar; Maryam Doostan; Nazanin Khoshnevisan; Farshad Sharifi
Journal:  J Nanobiotechnology       Date:  2021-10-12       Impact factor: 10.435

9.  Cdk2 silencing via a DNA/PCL electrospun scaffold suppresses proliferation and increases death of breast cancer cells.

Authors:  Clément Achille; Sowmya Sundaresh; Benjamin Chu; Michael Hadjiargyrou
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.